- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
GLC-GLC.7: 13 residues within 4Å:- Chain A: R.20, K.30, W.31, H.34
- Chain B: V.349, L.353, N.356
- Chain C: D.9, V.10, Q.12, E.14
- Ligands: Q3G.16, PLM.34
4 PLIP interactions:1 interactions with chain C, 1 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: C:D.9, B:N.356, A:R.20, A:K.30
GLC-GLC.8: 13 residues within 4Å:- Chain A: D.9, V.10, Q.12, E.14
- Chain B: R.20, K.30, W.31, H.34
- Chain C: V.349, L.353, N.356
- Ligands: Q3G.29, PLM.47
4 PLIP interactions:1 interactions with chain A, 2 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: A:D.9, B:R.20, B:K.30, C:N.356
GLC-GLC.9: 13 residues within 4Å:- Chain A: V.349, L.353, N.356
- Chain B: D.9, V.10, Q.12, E.14
- Chain C: R.20, K.30, W.31, H.34
- Ligands: PLM.21, Q3G.42
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: A:N.356, B:D.9, C:R.20, C:K.30
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
GDP.10: 18 residues within 4Å:- Chain A: R.546, H.547, Y.550, A.554, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:Y.550, A:A.567, A:A.567, A:A.567, A:L.569, A:R.574, A:R.574, A:S.589
- Salt bridges: A:R.546, A:R.546, A:H.547, A:H.547, A:R.578, A:K.583
- pi-Stacking: A:F.591
GDP.23: 18 residues within 4Å:- Chain B: R.546, H.547, Y.550, A.554, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
16 PLIP interactions:16 interactions with chain B- Hydrogen bonds: B:S.543, B:Y.550, B:A.567, B:A.567, B:A.567, B:L.569, B:R.574, B:R.574, B:S.589
- Salt bridges: B:R.546, B:R.546, B:H.547, B:H.547, B:R.578, B:K.583
- pi-Stacking: B:F.591
GDP.36: 18 residues within 4Å:- Chain C: R.546, H.547, Y.550, A.554, A.564, D.565, F.566, A.567, I.568, L.569, R.574, R.578, K.583, Y.588, S.589, G.590, F.591, K.592
15 PLIP interactions:15 interactions with chain C- Hydrogen bonds: C:Y.550, C:A.567, C:A.567, C:A.567, C:L.569, C:R.574, C:R.574, C:S.589
- Salt bridges: C:R.546, C:R.546, C:H.547, C:H.547, C:R.578, C:K.583
- pi-Stacking: C:F.591
- 6 x ZN: ZINC ION(Non-covalent)
ZN.11: 6 residues within 4Å:- Chain A: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.479, A:C.499, A:C.506, A:C.572
ZN.12: 6 residues within 4Å:- Chain A: C.477, Q.478, C.479, C.482, C.498, C.499
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.477, A:C.479, A:C.482, A:C.498
ZN.24: 6 residues within 4Å:- Chain B: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.479, B:C.499, B:C.506, B:C.572
ZN.25: 5 residues within 4Å:- Chain B: C.477, Q.478, C.479, C.482, C.498
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.477, B:C.479, B:C.482, B:C.498
ZN.37: 6 residues within 4Å:- Chain C: C.479, N.481, C.499, C.506, I.507, C.572
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.479, C:C.499, C:C.506, C:C.572
ZN.38: 6 residues within 4Å:- Chain C: C.477, Q.478, C.479, C.482, C.498, C.499
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.477, C:C.479, C:C.482, C:C.498
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 1 residues within 4Å:- Chain A: N.202
No protein-ligand interaction detected (PLIP)NAG.14: 4 residues within 4Å:- Chain A: N.213, S.215, C.216, N.223
No protein-ligand interaction detected (PLIP)NAG.15: 4 residues within 4Å:- Chain A: N.284, E.285, S.286
- Chain C: G.211
No protein-ligand interaction detected (PLIP)NAG.26: 1 residues within 4Å:- Chain B: N.202
No protein-ligand interaction detected (PLIP)NAG.27: 4 residues within 4Å:- Chain B: N.213, S.215, C.216, N.223
No protein-ligand interaction detected (PLIP)NAG.28: 4 residues within 4Å:- Chain A: G.211
- Chain B: N.284, E.285, S.286
No protein-ligand interaction detected (PLIP)NAG.39: 1 residues within 4Å:- Chain C: N.202
No protein-ligand interaction detected (PLIP)NAG.40: 4 residues within 4Å:- Chain C: N.213, S.215, C.216, N.223
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.223
NAG.41: 4 residues within 4Å:- Chain B: G.211
- Chain C: N.284, E.285, S.286
No protein-ligand interaction detected (PLIP)- 3 x Q3G: O-[(R)-[(2S)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy](hydroxy)phosphoryl]-D-serine(Non-covalent)
Q3G.16: 17 residues within 4Å:- Chain A: F.38, V.41, S.42, L.45, I.337, L.341, F.344, G.345, T.348
- Chain B: S.342, Y.343, L.346, V.349
- Chain C: N.16
- Ligands: GLC-GLC.7, Q3G.29, Q3G.42
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.41, A:L.341, A:L.341, A:F.344, B:L.346, B:V.349
- Hydrogen bonds: A:L.341
Q3G.29: 15 residues within 4Å:- Chain B: F.38, V.41, I.337, L.341, F.344, G.345, T.348
- Chain C: S.342, Y.343, G.345, L.346, V.349
- Ligands: GLC-GLC.8, Q3G.16, Q3G.42
7 PLIP interactions:5 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:V.41, B:L.341, B:L.341, B:F.344, C:L.346, C:V.349
- Hydrogen bonds: B:L.341
Q3G.42: 17 residues within 4Å:- Chain A: S.342, Y.343, G.345, L.346, V.349
- Chain B: N.16
- Chain C: F.38, V.41, S.42, I.337, L.341, F.344, G.345, T.348
- Ligands: GLC-GLC.9, Q3G.16, Q3G.29
7 PLIP interactions:2 interactions with chain A, 5 interactions with chain C- Hydrophobic interactions: A:L.346, A:V.349, C:V.41, C:L.341, C:L.341, C:F.344
- Hydrogen bonds: C:L.341
- 18 x PLM: PALMITIC ACID(Covalent)
PLM.17: 9 residues within 4Å:- Chain A: L.353, T.357, S.360, C.362, C.363
- Chain B: C.4
- Ligands: PLM.18, PLM.21, PLM.35
Ligand excluded by PLIPPLM.18: 9 residues within 4Å:- Chain A: C.350, L.353, I.354, T.357, Y.358, C.363, V.367
- Ligands: PLM.17, PLM.19
Ligand excluded by PLIPPLM.19: 5 residues within 4Å:- Chain A: Y.358, V.367, C.371, C.374
- Ligands: PLM.18
Ligand excluded by PLIPPLM.20: 10 residues within 4Å:- Chain A: V.24, N.25, Y.26, T.28, I.29, I.354, Y.358, C.377, N.380
- Chain C: F.11
Ligand excluded by PLIPPLM.21: 10 residues within 4Å:- Chain A: L.353, N.356, T.357, S.360, C.362
- Chain B: C.4
- Ligands: GLC-GLC.9, GLC-GLC.9, PLM.17, PLM.35
Ligand excluded by PLIPPLM.22: 4 residues within 4Å:- Chain A: C.4, C.5
- Ligands: PLM.43, PLM.47
Ligand excluded by PLIPPLM.30: 9 residues within 4Å:- Chain B: L.353, T.357, C.362, R.366, V.367
- Chain C: C.4
- Ligands: PLM.31, PLM.34, PLM.48
Ligand excluded by PLIPPLM.31: 9 residues within 4Å:- Chain B: C.350, L.353, I.354, T.357, Y.358, C.363, V.367
- Ligands: PLM.30, PLM.32
Ligand excluded by PLIPPLM.32: 5 residues within 4Å:- Chain B: Y.358, V.367, C.371, C.374
- Ligands: PLM.31
Ligand excluded by PLIPPLM.33: 10 residues within 4Å:- Chain A: F.11
- Chain B: V.24, N.25, Y.26, T.28, I.29, I.354, Y.358, C.377, N.380
Ligand excluded by PLIPPLM.34: 10 residues within 4Å:- Chain B: L.353, N.356, T.357, S.360, C.362
- Chain C: C.4
- Ligands: GLC-GLC.7, GLC-GLC.7, PLM.30, PLM.48
Ligand excluded by PLIPPLM.35: 4 residues within 4Å:- Chain B: C.4, C.5
- Ligands: PLM.17, PLM.21
Ligand excluded by PLIPPLM.43: 10 residues within 4Å:- Chain A: C.4
- Chain C: L.353, T.357, C.362, C.363, R.366, V.367
- Ligands: PLM.22, PLM.44, PLM.47
Ligand excluded by PLIPPLM.44: 9 residues within 4Å:- Chain C: C.350, L.353, I.354, T.357, Y.358, C.363, V.367
- Ligands: PLM.43, PLM.45
Ligand excluded by PLIPPLM.45: 5 residues within 4Å:- Chain C: Y.358, V.367, C.371, C.374
- Ligands: PLM.44
Ligand excluded by PLIPPLM.46: 10 residues within 4Å:- Chain B: F.11
- Chain C: V.24, N.25, Y.26, T.28, I.29, I.354, Y.358, C.377, N.380
Ligand excluded by PLIPPLM.47: 10 residues within 4Å:- Chain A: C.4
- Chain C: L.353, N.356, T.357, S.360, C.362
- Ligands: GLC-GLC.8, GLC-GLC.8, PLM.22, PLM.43
Ligand excluded by PLIPPLM.48: 4 residues within 4Å:- Chain C: C.4, C.5
- Ligands: PLM.30, PLM.34
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCarthy, A.E. et al., Full-Length P2X7Structures Reveal How Palmitoylation Prevents Channel Desensitization. Cell (2019)
- Release Date
- 2019-10-23
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 3 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x Q3G: O-[(R)-[(2S)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy](hydroxy)phosphoryl]-D-serine(Non-covalent)
- 18 x PLM: PALMITIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McCarthy, A.E. et al., Full-Length P2X7Structures Reveal How Palmitoylation Prevents Channel Desensitization. Cell (2019)
- Release Date
- 2019-10-23
- Peptides
- P2X purinoceptor 7: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.